Cargando…

Expression analysis of cyclooxygenase-2 in patients suffering from esophageal squamous cell carcinoma

Esophageal squamous cell carcinoma (ESCC) is one of the aggressive malignancies and mechanisms underlying its pathogenesis remain unclear. Cyclooxygenase-2 (COX-2) enzyme system plays a crucial role in many gastrointestinal malignancies and is an important regulator of cell growth, proliferation, ap...

Descripción completa

Detalles Bibliográficos
Autores principales: Tasneem, Shahida, Sarwar, Muhammad Tahir, Bashir, Muhammad Rizwan, Hussain, Hamid, Ahmed, Jawad, Pervez, Shahid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6195262/
https://www.ncbi.nlm.nih.gov/pubmed/30339710
http://dx.doi.org/10.1371/journal.pone.0205508
_version_ 1783364364445679616
author Tasneem, Shahida
Sarwar, Muhammad Tahir
Bashir, Muhammad Rizwan
Hussain, Hamid
Ahmed, Jawad
Pervez, Shahid
author_facet Tasneem, Shahida
Sarwar, Muhammad Tahir
Bashir, Muhammad Rizwan
Hussain, Hamid
Ahmed, Jawad
Pervez, Shahid
author_sort Tasneem, Shahida
collection PubMed
description Esophageal squamous cell carcinoma (ESCC) is one of the aggressive malignancies and mechanisms underlying its pathogenesis remain unclear. Cyclooxygenase-2 (COX-2) enzyme system plays a crucial role in many gastrointestinal malignancies and is an important regulator of cell growth, proliferation, apoptosis, differentiation and transformation. More precise outcome of COX-2 in ESCC is less investigated. In this study we investigated the risk factors of ESCC and expression of COX-2 in Carcinoma in situ (CIS) and ESCC compared to normal esophageal mucosa. ESCC relationship to clinico-pathological parameters using immunohistochemistry was also part of this investigation. Current study was conducted in the Institute of Basic Medical Sciences, Khyber Medical University, Peshawar, Pakistan. A total of 69 diagnosed patients of ESCC, both Pakistanis and Afghans were enrolled. Various risk factors associated with ESCC were recorded. Mean age at the time of diagnosis was 55 years. Out of 69 patients of ESCC 46 (67%) were users of dipping tobacco (Naswar). Expression of COX-2 was determined in normal esophageal mucosa, CIS and invasive ESCC using Immunohistochemistry (IHC). Differences of mean were computed using ANOVA followed by applying Post Hoc test. Patients were categorized as positive with high expression or negative with low to nil expression. ANOVA showed large differences in expression of COX-2 in normal healthy mucosa compared with CIS and ESCC with the mean difference of -9.529 and -7.370 respectively, p-value being <.05 at 95% confidence interval (CI). No significant difference was noticed in the expression of COX-2 in CIS compared with ESCC with p-value >.05 at 95% CI. Our complete cohort (23–85 years) showed statistically significant difference in the expression of COX-2 gene in ESCC and CIS tissue samples compared with normal healthy mucosa. Results of this study indicate that over-expression of COX-2 is positively associated with ESCC.
format Online
Article
Text
id pubmed-6195262
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-61952622018-11-19 Expression analysis of cyclooxygenase-2 in patients suffering from esophageal squamous cell carcinoma Tasneem, Shahida Sarwar, Muhammad Tahir Bashir, Muhammad Rizwan Hussain, Hamid Ahmed, Jawad Pervez, Shahid PLoS One Research Article Esophageal squamous cell carcinoma (ESCC) is one of the aggressive malignancies and mechanisms underlying its pathogenesis remain unclear. Cyclooxygenase-2 (COX-2) enzyme system plays a crucial role in many gastrointestinal malignancies and is an important regulator of cell growth, proliferation, apoptosis, differentiation and transformation. More precise outcome of COX-2 in ESCC is less investigated. In this study we investigated the risk factors of ESCC and expression of COX-2 in Carcinoma in situ (CIS) and ESCC compared to normal esophageal mucosa. ESCC relationship to clinico-pathological parameters using immunohistochemistry was also part of this investigation. Current study was conducted in the Institute of Basic Medical Sciences, Khyber Medical University, Peshawar, Pakistan. A total of 69 diagnosed patients of ESCC, both Pakistanis and Afghans were enrolled. Various risk factors associated with ESCC were recorded. Mean age at the time of diagnosis was 55 years. Out of 69 patients of ESCC 46 (67%) were users of dipping tobacco (Naswar). Expression of COX-2 was determined in normal esophageal mucosa, CIS and invasive ESCC using Immunohistochemistry (IHC). Differences of mean were computed using ANOVA followed by applying Post Hoc test. Patients were categorized as positive with high expression or negative with low to nil expression. ANOVA showed large differences in expression of COX-2 in normal healthy mucosa compared with CIS and ESCC with the mean difference of -9.529 and -7.370 respectively, p-value being <.05 at 95% confidence interval (CI). No significant difference was noticed in the expression of COX-2 in CIS compared with ESCC with p-value >.05 at 95% CI. Our complete cohort (23–85 years) showed statistically significant difference in the expression of COX-2 gene in ESCC and CIS tissue samples compared with normal healthy mucosa. Results of this study indicate that over-expression of COX-2 is positively associated with ESCC. Public Library of Science 2018-10-19 /pmc/articles/PMC6195262/ /pubmed/30339710 http://dx.doi.org/10.1371/journal.pone.0205508 Text en © 2018 Tasneem et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Tasneem, Shahida
Sarwar, Muhammad Tahir
Bashir, Muhammad Rizwan
Hussain, Hamid
Ahmed, Jawad
Pervez, Shahid
Expression analysis of cyclooxygenase-2 in patients suffering from esophageal squamous cell carcinoma
title Expression analysis of cyclooxygenase-2 in patients suffering from esophageal squamous cell carcinoma
title_full Expression analysis of cyclooxygenase-2 in patients suffering from esophageal squamous cell carcinoma
title_fullStr Expression analysis of cyclooxygenase-2 in patients suffering from esophageal squamous cell carcinoma
title_full_unstemmed Expression analysis of cyclooxygenase-2 in patients suffering from esophageal squamous cell carcinoma
title_short Expression analysis of cyclooxygenase-2 in patients suffering from esophageal squamous cell carcinoma
title_sort expression analysis of cyclooxygenase-2 in patients suffering from esophageal squamous cell carcinoma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6195262/
https://www.ncbi.nlm.nih.gov/pubmed/30339710
http://dx.doi.org/10.1371/journal.pone.0205508
work_keys_str_mv AT tasneemshahida expressionanalysisofcyclooxygenase2inpatientssufferingfromesophagealsquamouscellcarcinoma
AT sarwarmuhammadtahir expressionanalysisofcyclooxygenase2inpatientssufferingfromesophagealsquamouscellcarcinoma
AT bashirmuhammadrizwan expressionanalysisofcyclooxygenase2inpatientssufferingfromesophagealsquamouscellcarcinoma
AT hussainhamid expressionanalysisofcyclooxygenase2inpatientssufferingfromesophagealsquamouscellcarcinoma
AT ahmedjawad expressionanalysisofcyclooxygenase2inpatientssufferingfromesophagealsquamouscellcarcinoma
AT pervezshahid expressionanalysisofcyclooxygenase2inpatientssufferingfromesophagealsquamouscellcarcinoma